FDA Approvals of Brand-Name Prescription Drugs in 2014

Схожие документы

• FDA Approvals of Brand-Name Prescription Drugs in 2015
  Опубликовано: (2016)
• Reporting of Drug Benefit in FDA-Approved Prescription Drug Labeling
  по: Desai, Bansri, et al.
  Опубликовано: (2019)
• Jakafi (Ruxolitinib): First FDA-Approved Medication for the Treatment of Patients with Polycythemia Vera
  по: Raedler, Lisa A.
  Опубликовано: (2015)
• New FDA Drug Approvals Hit an 18-Year High in 2014
  по: Owens, Gary M.
  Опубликовано: (2015)
• Jardiance (Empagliflozin), an SGLT2 Inhibitor, Receives FDA Approval for the Treatment of Patients with Type 2 Diabetes
  по: Fala, Loretta
  Опубликовано: (2015)